Minimally invasive surgical (MIS) technologies are one of the leading contributors to the global medical device market. In the year 2017, the MIS technologies held the 7th largest contributing share to the medical device market's global revenue. However, the rising number of COVID-19 cases across the globe has resulted in massive pressure on the healthcare community. With no left options, governments worldwide are forced to recommend the healthcare community to postpone elective surgeries and medical procedures as a plan-of-action to cope with the pressure. The rollout of the recommendations resulted in a massive decrease in every-day MIS procedures and consequentially impacted the global revenue of the MIS technology ecosystem.